NCT05828082 2026-04-14Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate CancerNational Cancer Institute (NCI)Phase 2 Active not recruiting20 enrolled
NCT01841723 2026-04-13Ibrutinib in Treating Patients With Relapsed Hairy Cell LeukemiaNational Cancer Institute (NCI)Phase 2 Active not recruiting44 enrolled